Institute of Biomedical Engineering, University of Toronto, Toronto, Ontario M5S 3G9, Canada; Toronto General Hospital Research Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.
David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Trends Biotechnol. 2023 Mar;41(3):410-424. doi: 10.1016/j.tibtech.2022.12.018. Epub 2023 Jan 31.
We review the emergence of the new field of organ-on-a-chip (OOAC) engineering, from the parent fields of tissue engineering and microfluidics. We place into perspective the tools and capabilities brought into the OOAC field by early tissue engineers and microfluidics experts. Liver-on-a-chip and heart-on-a-chip are used as two case studies of systems that heavily relied on tissue engineering techniques and that were amongst the first OOAC models to be implemented, motivated by the need to better assess toxicity to human tissues in preclinical drug development. We review current challenges in OOAC that often stem from the same challenges in the parent fields, such as stable vascularization and drug absorption.
我们回顾了器官芯片(OOAC)工程这一新领域的出现,它源自组织工程学和微流控学这两个母体领域。我们从早期的组织工程学专家和微流控学专家为 OOAC 领域带来的工具和能力的角度来看待这个问题。肝芯片和心芯片被用作两个案例研究,这两个系统严重依赖组织工程技术,并且是最早实施的 OOAC 模型之一,其动机是需要在临床前药物开发中更好地评估对人体组织的毒性。我们回顾了 OOAC 目前面临的挑战,这些挑战往往源于母体领域中的相同挑战,例如稳定的血管化和药物吸收。